Literature DB >> 28993904

Management of radiation-induced mucosal necrosis with photobiomodulation therapy.

Caroline de Bataille1, Vincent Sibaud2, Angélique Prioul3, Anne Laprie4,5, Emmanuelle Vigarios6,7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28993904     DOI： 10.1007/s00520-017-3899-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  10 in total

1.  Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts.

Authors:  Aymann Nassif Pereira; Carlos de Paula Eduardo; Edmir Matson; Márcia Martins Marques
Journal:  Lasers Surg Med       Date:  2002       Impact factor: 4.025

2.  Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Authors:  D E Peterson; C B Boers-Doets; R J Bensadoun; J Herrstedt
Journal:  Ann Oncol       Date:  2015-07-04       Impact factor: 32.976

3.  Chronic oral mucositis after radiotherapy to the head and neck: a new insight.

Authors:  Sharon Elad; Yehuda Zadik
Journal:  Support Care Cancer       Date:  2016-07-30       Impact factor: 3.603

4.  Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients.

Authors:  Joel B Epstein; Paul Y Song; Allen S Ho; Babak Larian; Arash Asher; Rene-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-12-17       Impact factor: 3.603

Review 5.  Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Stephen T Sonis; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

Review 6.  Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

Review 7.  Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.

Authors:  Stephen T Sonis; Sepehr Hashemi; Joel B Epstein; Raj G Nair; Judith E Raber-Durlacher
Journal:  Oral Oncol       Date:  2016-02-03       Impact factor: 5.337

Review 8.  Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Authors:  Emmanuelle Vigarios; Joel B Epstein; Vincent Sibaud
Journal:  Support Care Cancer       Date:  2017-02-22       Impact factor: 3.603

9.  Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.

Authors:  Joel B Epstein; Judith E Raber-Durlacher; Michael Lill; Yuliya P L Linhares; Jerry Chang; Andrei Barasch; Romée I C Slief; Margot Geuke; Judith A E M Zecha; Dan M J Milstein; D Tzachanis
Journal:  Support Care Cancer       Date:  2016-09-21       Impact factor: 3.603

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860
  10 in total
  1 in total

1.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.